Allarity Therapeutics, Inc. (ALLR) stock
ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84−0.03 (-3.91%)
Close on Nov 17, 2026Market cap $13.38MP/E –Yield –
Allarity Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Allarity Therapeutics's total assets was $32.12M at Jun 30, 2026. For fiscal 2025 it was $18.26M, down 19.4% from the year before. The highest annual figure on record is $49.63M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.26M | -19.4% |
| FY2024 | Dec 31, 2024 | $22.65M | +90.9% |
| FY2023 | Dec 31, 2023 | $11.86M | -18.4% |
| FY2022 | Dec 31, 2022 | $14.54M | -70.7% |
| FY2021 | Dec 31, 2021 | $49.63M | +48.6% |
| FY2020 | Dec 31, 2020 | $33.40M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $32.12M | +51.5% |
| Q1 FY2026 | Mar 31, 2026 | $34.92M | +17.5% |
| Q4 FY2025 | Dec 31, 2025 | $18.26M | -19.4% |
| Q3 FY2025 | Sep 30, 2025 | $20.80M | +2.1% |
| Q2 FY2025 | Jun 30, 2025 | $21.21M | -31.3% |
| Q1 FY2025 | Mar 31, 2025 | $29.73M | +148.4% |
| Q4 FY2024 | Dec 31, 2024 | $22.65M | +90.9% |
| Q3 FY2024 | Sep 30, 2024 | $20.38M | +46.9% |
| Q2 FY2024 | Jun 30, 2024 | $30.88M | +130.0% |
| Q1 FY2024 | Mar 31, 2024 | $11.97M | -17.7% |
| Q4 FY2023 | Dec 31, 2023 | $11.86M | -34.6% |
| Q3 FY2023 | Sep 30, 2023 | $13.88M | -40.3% |
| Q2 FY2023 | Jun 30, 2023 | $13.43M | -57.1% |
| Q4 FY2022 | Dec 31, 2022 | $14.54M | -70.7% |
| Q3 FY2022 | Sep 30, 2022 | $18.13M | -51.0% |
| Q2 FY2022 | Jun 30, 2022 | $23.23M | -30.5% |
| Q1 FY2022 | Mar 31, 2022 | $31.29M | – |
| Q4 FY2021 | Dec 31, 2021 | $49.63M | – |
| Q3 FY2021 | Sep 30, 2021 | $36.99M | – |
| Q4 FY2020 | Dec 31, 2020 | $33.40M | – |
See a number that looks wrong?